Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...

University of Wisconsin-Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

Second, CRISPR-Cas9 and other DNA editing tools require proteins acquired ... Researchers used them to great success to make ...

Crispr/Cas9 works by having Crispr (pieces of DNA sequences ... engineered at a lab that uses randomly integrated viruses to deliver specific cancer markers, and reinfused back into the patient’s body ...

For the past decade, scientists have relied almost exclusively on CRISPR-Cas systems for genome editing. Now, a smaller but ...

"It's a completely brand-new type of CRISPR chemistry," says co-first author Christian Baca, a TPCB graduate student in the Marraffini lab. "It's more evidence that CRISPR systems have an array of ...

Researchers discovered that the CRISPR-Cas10 system not only cuts viral DNA but also produces toxic cyclic-oligoadenylates ...